Black Diamond Therapeutics

BDTX

Market cap $159M

2.67 USD

-0.12

4.3%

At close Updated Jan 15, 4:00 PM EST

Pre-market

After hours

2.67

0.00

1 day

-4.3%

5 days

-5.32%

1 month

0.75%

3 months

-35.66%

6 months

-9.49%

Year to date

7.23%

1 year

26.54%

5 years

-90.09%

10 years

-93.24%

About: Black Diamond Therapeutics Inc is a clinical-stage oncology company developing MasterKey therapies that target families of oncogenic mutations in patients with cancer. It is engaged in the discovery and development of small molecule, tumor-agnostic therapies. The company has one pipeline technology platform, namely Mutation-Allostery-Pharmacology, which is targeting mutations in cancer. Its drugs under the pipeline are BDTX-4933 and BDTX-1535.

Employees: 54

Healthcare Biotechnology